The efficacy and safety of novel oral anticoagulants for the preventive treatment in atrial fibrillation patients: a systematic review and meta-analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of novel oral anticoagulants for the preventive treatment in atrial fibrillation patients: a systematic review and meta-analysis
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 21, Issue 6, Pages 436-452
Publisher
Informa UK Limited
Online
2014-01-08
DOI
10.3109/10717544.2013.873500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial
- (2013) Jonas Oldgren ANNALS OF INTERNAL MEDICINE
- Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)
- (2013) S. J. Connolly et al. EUROPEAN HEART JOURNAL
- Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis
- (2013) J.-C. Lega et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
- (2012) Corey S. Miller et al. AMERICAN JOURNAL OF CARDIOLOGY
- Bleeding of New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
- (2012) Joey S. W. Kwong et al. CARDIOVASCULAR DRUGS AND THERAPY
- Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
- (2012) Francesco Dentali et al. CIRCULATION
- Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation
- (2012) Takeshi Yamashita et al. CIRCULATION JOURNAL
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
- (2012) J.-P. Bassand EUROPACE
- Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban
- (2012) Stavros Apostolakis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
- (2012) Graeme J Hankey et al. LANCET NEUROLOGY
- Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial
- (2012) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
- (2012) J Donald Easton et al. LANCET NEUROLOGY
- Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation
- (2012) L. Testa et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin
- (2012) Greg C. Flaker et al. STROKE
- Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
- (2012) George Ntaios et al. STROKE
- Prognostic factors in non-surgically treated sciatica: A systematic review
- (2011) Julie Ashworth et al. BMC MUSCULOSKELETAL DISORDERS
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
- (2011) G. Y. H. LIP JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation
- (2010) Michael D. Ezekowitz et al. CIRCULATION
- Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation
- (2010) Yat-Yin Lam et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
- (2010) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
- (2010) Terry K.W. Ma et al. PHARMACOLOGY & THERAPEUTICS
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
- (2010) Stuart Connolly et al. THROMBOSIS AND HAEMOSTASIS
- Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation
- (2010) Lars Rasmussen et al. THROMBOSIS AND HAEMOSTASIS
- Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation
- (2010) Hui-Kyung Jeon et al. THROMBOSIS AND HAEMOSTASIS
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
- (2010) Gregory Y.H. Lip et al. THROMBOSIS RESEARCH
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
- (2009) G. Y.H. Lip et al. EUROPEAN HEART JOURNAL
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial
- (2008) Marco J.D. Tangelder et al. AMERICAN HEART JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started